Shindo T, Hashimoto K, Takahashi A, Miyamoto S, et al. Comparison of Oncological Outcomes of Pembrolizumab as Second-line Therapy and Maintenance Avelumab Therapy in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy. Anticancer Res 2024;44:1271-1279.
PMID: 38423657